Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recombinant LH Supplementation Timing Strategies (From Day 1 or Day 6) to a Standard GnRH Agonist Long Protocol in Subsequent COS Cycle of Older Patients With Unexpected Poor or Suboptimal Ovarian Response

NCT04178135 is registered in ClinicalTrials.gov with Reproductive & Genetic Hospital of CITIC-Xiangya as lead sponsor.

NCT NCT04178135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04178135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recombinant LH Supplementation Timing Strategies (From Day 1 or Day 6) to a Standard GnRH Agonist Long Protocol in Subsequent COS Cycle of Older Patients With Unexpected Poor or Suboptimal Ovarian Response
Lead sponsor
Reproductive & Genetic Hospital of CITIC-Xiangya
Phase
Not applicable
Overall status
Unknown status
Start date
December 25, 2019
Completion date
December 30, 2022
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

infertility,female